LNSR Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 16:00):

Stats
Today's Volume	76 394.00
Average Volume	41 795.00
Market Cap	36.92M
EPS	$-0.350 ( 2024-03-04 )
Next earnings date	( $-0.280 ) 2024-05-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.47
ATR14	$0.0450 (1.39%)

Insider Trading

Date	Person	Action	Amount	type
2023-11-22	Winer Gary M	Buy	300	Common Stock
2023-11-16	Winer Gary M	Buy	1 000	Common Stock
2023-11-15	Winer Gary M	Buy	500	Common Stock
2023-11-10	Winer Gary M	Buy	1 000	Common Stock
2023-08-11	Winer Gary M	Buy	705	Common Stock

INSIDER POWER
100.00
Last 94 transactions
Buy: 2 011 316 \| Sell: 8 672 727

Volume Correlation

Long: 0.17 (neutral)

Short: -0.47 (neutral)

Signal:(52.636) Neutral

LENSAR, Inc. Correlation

10 Most Positive Correlations
RMRM	0.931
DVLU	0.868
GAINL	0.857
PFI	0.848
ESQ	0.842
CPLP	0.838
SALM	0.837
ARCC	0.831
STEP	0.829
FV	0.828

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

LENSAR, Inc. Correlation - Currency/Commodity

0.57
( weak )

0.64
( weak )

0.00
( neutral )

0.53
( weak )

-0.59
( weak negative )

-0.11
( neutral )

LENSAR, Inc. Financials

Annual	2023
Revenue:	$42.16M
Gross Profit:	$20.01M (47.46 %)
EPS:	$-1.310

FY	2023
Revenue:	$42.16M
Gross Profit:	$20.01M (47.46 %)
EPS:	$-1.310

FY	2022
Revenue:	$35.36M
Gross Profit:	$19.96M (56.44 %)
EPS:	$-1.930

FY	2021
Revenue:	$34.46M
Gross Profit:	$17.83M (51.75 %)
EPS:	$-2.09

Financial Reports:

No articles found.

LENSAR, Inc.

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.